M. Ian Somaiya
Stock Analyst at BMO Capital
(1.50)
# 3,309
Out of 4,931 analysts
13
Total ratings
58.33%
Success rate
-2.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by M. Ian Somaiya
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Maintains: Outperform | $82 → $81 | $110.28 | -26.55% | 5 | Oct 25, 2019 | |
| PTGX Protagonist Therapeutics | Initiates: Outperform | $17 | $50.96 | -66.64% | 6 | Feb 22, 2019 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $119 → $125 | $59.46 | +110.23% | 2 | Feb 23, 2018 |
Gilead Sciences
Oct 25, 2019
Maintains: Outperform
Price Target: $82 → $81
Current: $110.28
Upside: -26.55%
Protagonist Therapeutics
Feb 22, 2019
Initiates: Outperform
Price Target: $17
Current: $50.96
Upside: -66.64%
BioMarin Pharmaceutical
Feb 23, 2018
Maintains: Outperform
Price Target: $119 → $125
Current: $59.46
Upside: +110.23%